Agency Information Collection Activities; Submission for Office and Management and Budget Review; Comment Request; Guidance for Industry on How to Submit a Notice of Final Disposition of Investigational Animals Not Intended for Immediate Slaughter in Electronic Format to the Center for Veterinary Medicine, 22598 [2010-9901]
Download as PDF
22598
Federal Register / Vol. 75, No. 82 / Thursday, April 29, 2010 / Notices
Dated: April 23, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0453. Also
include the FDA docket number found
in brackets in the heading of this
document.
ADDRESSES:
[FR Doc. 2010–9902 Filed 4–28–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0034]
Agency Information Collection
Activities; Submission for Office and
Management and Budget Review;
Comment Request; Guidance for
Industry on How to Submit a Notice of
Final Disposition of Investigational
Animals Not Intended for Immediate
Slaughter in Electronic Format to the
Center for Veterinary Medicine
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
3793.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Food and Drug Administration,
HHS.
ACTION:
Notice.
Guidance for Industry on How to
Submit a Notice of Final Disposition of
Investigational Animals Not Intended
for Immediate Slaughter in Electronic
Format to the Center for Veterinary
Medicine—(OMB Control Number
0910–0453)—Extension
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by June 1,
2010.
animals do not enter the human food
chain immediately at the completion of
an investigational study. CVM’s
monitoring of the final disposition of
investigational food animals is intended
to ensure that unsafe residues of new
animal drugs do not get into the food
supply. CVM issues a slaughter
authorization letter to investigational
new animal drug (INAD) sponsors that
sets the terms under which
investigational animals may be
slaughtered (21 CFR 511.1(b)(5)). Also
in the letter, CVM requests that sponsors
submit a notice of final disposition of
investigational animals (NFDA) not
intended for immediate slaughter.
NFDAs have historically been submitted
to CVM on paper. CVM’s guidance
entitled ‘‘How to Submit a Notice of
Final Disposition of Investigational
Animals not Intended for Immediate
Slaughter in Electronic Format to CVM’’
provides sponsors with an option to
submit an NFDA as an e-mail
attachment to CVM via the Internet.
The likely respondents are INAD
sponsors.
FDA estimates the burden of this
collection of information as follows:
The Center for Veterinary Medicine
(CVM) monitors the final disposition of
investigational animals where such
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
21 CFR Section/
Form No. 3487
Number of
Respondents
511.1(b)(5)
1 There
Annual Frequency
per Response
40
Total Annual
Responses 2
0.4
Hours per
Response
16
Total Hours
.08
1.3
are no capital or operating and maintenance costs associated with this collection of information.
submissions received between January 1, 2008, and December 31, 2008.
2 Electronic
mstockstill on DSKH9S0YB1PROD with NOTICES
The number of respondents in table 1
of this document are the number of
sponsors registered to make electronic
submissions (40). The number of total
annual responses is based on a review
of the actual number of such
submissions made between January 1,
2008, and December 31, 2008. Thus,
FDA estimates the total reporting
burden at 1.3 hours (16 x .08= 1.3 total
hours).
Dated: April 23, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–9901 Filed 4–28–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0055]
Agency Information Collection
Activities; Submission for Office and
Management and Budget Review;
Comment Request; Guidance for
Industry on How to Submit a Protocol
Without Data in Electronic Format to
the Center for Veterinary Medicine
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
VerDate Mar<15>2010
16:19 Apr 28, 2010
Jkt 220001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by June 1,
2010.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0524. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
E:\FR\FM\29APN1.SGM
29APN1
Agencies
[Federal Register Volume 75, Number 82 (Thursday, April 29, 2010)]
[Notices]
[Page 22598]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9901]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-D-0034]
Agency Information Collection Activities; Submission for Office
and Management and Budget Review; Comment Request; Guidance for
Industry on How to Submit a Notice of Final Disposition of
Investigational Animals Not Intended for Immediate Slaughter in
Electronic Format to the Center for Veterinary Medicine
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by June
1, 2010.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0453.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-3793.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Guidance for Industry on How to Submit a Notice of Final Disposition of
Investigational Animals Not Intended for Immediate Slaughter in
Electronic Format to the Center for Veterinary Medicine--(OMB Control
Number 0910-0453)--Extension
The Center for Veterinary Medicine (CVM) monitors the final
disposition of investigational animals where such animals do not enter
the human food chain immediately at the completion of an
investigational study. CVM's monitoring of the final disposition of
investigational food animals is intended to ensure that unsafe residues
of new animal drugs do not get into the food supply. CVM issues a
slaughter authorization letter to investigational new animal drug
(INAD) sponsors that sets the terms under which investigational animals
may be slaughtered (21 CFR 511.1(b)(5)). Also in the letter, CVM
requests that sponsors submit a notice of final disposition of
investigational animals (NFDA) not intended for immediate slaughter.
NFDAs have historically been submitted to CVM on paper. CVM's guidance
entitled ``How to Submit a Notice of Final Disposition of
Investigational Animals not Intended for Immediate Slaughter in
Electronic Format to CVM'' provides sponsors with an option to submit
an NFDA as an e-mail attachment to CVM via the Internet.
The likely respondents are INAD sponsors.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Annual Frequency Total Annual
21 CFR Section/ Form No. 3487 Respondents per Response Responses \2\ Hours per Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
511.1(b)(5) 40 0.4 16 .08 1.3
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital or operating and maintenance costs associated with this collection of information.
\2\ Electronic submissions received between January 1, 2008, and December 31, 2008.
The number of respondents in table 1 of this document are the
number of sponsors registered to make electronic submissions (40). The
number of total annual responses is based on a review of the actual
number of such submissions made between January 1, 2008, and December
31, 2008. Thus, FDA estimates the total reporting burden at 1.3 hours
(16 x .08= 1.3 total hours).
Dated: April 23, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-9901 Filed 4-28-10; 8:45 am]
BILLING CODE 4160-01-S